The Correlation of Biological Activity and Chemical Structure of Quinolizidinyl Derivatives as Inhibitor of Alzheimer's Disease with Linear and Non-linear Models

被引:0
|
作者
Ghasemi, G. [1 ]
Rashtehroodi, A. Nemati [2 ]
机构
[1] Islamic Azad Univ, Rasht Branch, Dept Chem, Rasht, Iran
[2] Payame Noor Univ, Dept Chem, Sari Branch, Sari, Iran
来源
ANALYTICAL AND BIOANALYTICAL CHEMISTRY RESEARCH | 2016年 / 3卷 / 02期
关键词
QSAR model; Genetic Algorithm; Artificial Neural Network; Alzheimer's disease; Quinolizidinyl derivatives;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this research, QSAR study has been carried out on quinolizidinyl derivatives as potent inhibitors of Acetyl and butyrylcholin esterase in Alzheimer's disease. Despite significant research efforts in industry and academia, there are currently no diseases modifying therapies available to treat this illness. Significant evidence suggests that the pathology of AD is linked to generation of beta-amyloid peptides (A beta) through proteolytic processing of amyloid precursor protein (APP). Genetic algorithm (GA), Jack-Knife and stepwise multiple linear regressions (stepwise-MLR) were used to create non-linear and linear QSAR models. The root-mean square errors of the training set and the validation set for GA-ANN model using Jack-Knife method, were 0.1406, 0.2165 and R-2 was 0.90. Also, the R and R-2 values in the gas phase were obtained as 0.88 and 0.78 from GA-stepwise MLR model, respectively. Also, we suggest that compounds No. 4, 6, 10, 14, 24, 26 and 34 have the most appropriate structure for the design of drugs to pharmacists. Electronegativities, atomic polarizability and atomic van der Waals volumes were important descriptors in our study. Geometry optimization of compounds was carried out using the B3LYP method employing a 6-31G (d) basis set.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 43 条
  • [21] Design, synthesis and biological evaluation of novel pyrazolone derivatives as selective butyrylcholinesterase inhibitors with antioxidant activity against Alzheimer's disease
    Zhang, Zhipeng
    Cheng, Maojun
    Guo, Jie
    Wan, Yang
    Wang, Rikang
    Fang, Yuanying
    Jin, Yi
    Xie, Sai-Sai
    Liu, Jing
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1254
  • [22] Multifunctional Anti-Alzheimer's Disease Effects of Natural Xanthone Derivatives: A Primary Structure-Activity Evaluation
    Hu, Xiaoyu
    Liu, Chan
    Wang, Kaichun
    Zhao, Lanxue
    Qiu, Yu
    Chen, Hongzhuan
    Hu, Jiangmiao
    Xu, Jianrong
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [23] Design, synthesis, biological activity evaluation and in silico studies of new nicotinohydrazide derivatives as multi-targeted inhibitors for Alzheimer's disease
    Tok, Fatih
    Saglik, Begum Nurpelin
    Ozkay, Yusuf
    Kaplancikli, Zafer Asim
    Kocyigit-Kaymakcioglu, Bedia
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1265
  • [24] Deoxyvasicinone hybrids in the management of Alzheimer's disease: Recent advances on manmade derivatives, pharmacological activities, and structure-activity relationship
    Gaur, Ankur
    Singh, Yash Pal
    Sharma, Rajiv
    Bainsal, Neeraj
    ARCHIV DER PHARMAZIE, 2025, 358 (01)
  • [25] Synthesis and study of the biological activity of thiourea-containing amiridine derivatives as potential multi-target drugs for the treatment of Alzheimer's disease
    Makhaeva, G. F.
    Proshin, A. N.
    Kovaleva, N. V.
    Rudakova, E. V.
    Boltneva, N. P.
    Lushchekina, S. V.
    Astakhova, T. Y.
    Serkov, I. V.
    Kalashnikova, I. P.
    Bachurin, S. O.
    RUSSIAN CHEMICAL BULLETIN, 2022, 71 (11) : 2404 - 2415
  • [26] Synthesis, crystal structure and biological evaluation of novel 2-phenylthiazole derivatives as multi-targeting agents to treat Alzheimer's disease
    Shi, Da-Hua
    Tang, Zong-ming
    Ma, Xiao-Dong
    Min, Wei
    Xu, Xiang-Jian
    Liu, Yu-Wei
    Song, Xiao-Kai
    Liu, Wei-Wei
    Song, Meng-Qiu
    JOURNAL OF CHEMICAL RESEARCH, 2017, (09) : 551 - 555
  • [27] Synthesis and study of the biological activity of thiourea-containing amiridine derivatives as potential multi-target drugs for the treatment of Alzheimer’s disease
    G. F. Makhaeva
    A. N. Proshin
    N. V. Kovaleva
    E. V. Rudakova
    N. P. Boltneva
    S. V. Lushchekina
    T. Y. Astakhova
    I. V. Serkov
    I. P. Kalashnikova
    S. O. Bachurin
    Russian Chemical Bulletin, 2022, 71 : 2404 - 2415
  • [28] Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease
    Iraji, Aida
    Firuzi, Omidreza
    Khoshneviszadeh, Mehdi
    Nadri, Hamid
    Edraki, Najmeh
    Miri, Ramin
    BIOORGANIC CHEMISTRY, 2018, 77 : 223 - 235
  • [29] Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer's disease: an insight into structure-activity relationship
    Halder, Debojyoti
    Das, Subham
    Jeyaprakash, R. S.
    Joseph, Alex
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (20) : 11286 - 11323
  • [30] Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data
    Wang, Guoqiao
    Hassenstab, Jason
    Li, Yan
    Aschenbrenner, Andrew J.
    Mcdade, Eric M.
    Llibre-Guerra, Jorge
    Bateman, Randall J.
    Xiong, Chengjie
    STATISTICS IN MEDICINE, 2024, 43 (30) : 5898 - 5910